{
    "2020-09-29": [
        [
            {
                "time": "",
                "original_text": "发生了什么？军工股突然大爆发，两只20%涨停",
                "features": {
                    "keywords": [
                        "军工股",
                        "大爆发",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "军工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "另外，股价涨了这么多倍，一些股东、高管正在持续减持套现，这也会对公司股价形成一定打压。减持股份",
                "features": {
                    "keywords": [
                        "股价",
                        "上涨",
                        "减持",
                        "套现",
                        "打压"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "疫苗股走软，智飞生物、长春高新、康泰生物、复星医药、华兰生物、万泰生物普跌",
                "features": {
                    "keywords": [
                        "疫苗股",
                        "走软",
                        "普跌",
                        "智飞生物",
                        "长春高新",
                        "康泰生物",
                        "复星医药",
                        "华兰生物",
                        "万泰生物"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物新冠灭活疫苗获临床试验批件，车间已完成建设",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "新冠灭活疫苗",
                        "临床试验",
                        "批件",
                        "车间建设"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物(300601.SZ)：新型冠状病毒灭活疫苗(Vero细胞)获得临床试验批件",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "新型冠状病毒灭活疫苗",
                        "Vero细胞",
                        "临床试验批件"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：公司新型冠状病毒灭活疫苗（Vero细胞）获得临床试验批件",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "新型冠状病毒灭活疫苗",
                        "Vero细胞",
                        "临床试验批件"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}